Record #69363
Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P‑glycoprotein and MRPs expression
Journal
Publisher
Original paper date
Aug 27, 2020
Original DOI
Country
Institution
Department of General Surgery, Shanxian Central Hospital, Heze, Shandong 274300, P.R. China · Department of Neurosurgery, Shanxian Central Hospital, Heze, Shandong 274300, P.R. China · Department of Trauma Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China
Open access
No
Article type
Notes from Retraction Watch
See also: https://pubpeer.com/publications/46B71A878EE92C3D0D52A782CA1647
Citation lifecycle
How this paper is being cited
Pre-retraction
16
Same day
0
Post-retraction
3
% post-retraction
15.8%
~4.1 citations/yr before retraction · ~1.4 citations/yr after
— citing papers
Who is still citing this work
Loading…